Global /India /Healthcare /Medical Care Facilities /SURAKSHA
chevron_leftBack
Suraksha Diagnostic Ltd. logo

Suraksha Diagnostic Ltd.

SURAKSHA
NSE: SURAKSHA Delayed
283.95INR 1.1%
2.97 USD
As of 5 June 2026, Suraksha Diagnostic Ltd. has a market cap of $152.72M USD, ranking #22774 globally and #1327 in India. It ranks #2046 in the Healthcare sector, and #239 in the Medical Care Facilities industry.
Global Rank
22774
Country Rank
1327
Sector Rank
2046
Industry Rank
239
Key Stats
Market Cap
$152.72MUSD
14.62B INR
Enterprise Value
$160.35MUSD
15.35B INR
Revenue (TTM)
$30.71MUSD
2.94B INR
EBITDA (TTM)
$4.8MUSD
459.3M INR
Net Income (TTM)
$3.48MUSD
332.95M INR
EBITDA Margin
16%
Profit Margin
11%
PE Ratio
44.9
Forward PE
37.8
PS Ratio
5.0
PB Ratio
6.4
EV/EBITDA
24.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Ritu Mittal open_in_new
Employees
1,300
Founded
1992
Website
surakshanet.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1.1% -0.5% 19% 6.6% -13% -8.9%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
SURAKSHA
Suraksha Diagnostic Ltd
ISIN: INE877V01027
Shares Out.:
52.081M1 Shares Float: 26.62M2
TV:
SA:
YF:
GF:
BA:
MS:
283.95 INR
Bombay Stock Exchange
MIC: XBOM
544293 (SURAKSHA)
Suraksha Diagnostic Ltd
ISIN: INE877V01027
TV:
SA:
YF:
GF:
BA:
MS:
282.05 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Suraksha Diagnostic Ltd.

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company also provides Cardiology testing services comprises electrocardiogram, echocardiogram, stress test / treadmill test, wireless holter monitoring, colour doppler, peripheral doppler, and pulmonary function test; gastroenterology, such as upper and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy; and neurology testing services, including electroencephalogram, electromyography, and nerve conduction velocity test. In addition, the company provides dental, physiotherapy, immunology & rheumatology, eye, fetal care, ENT, and speciality clinics, as well as home doctor visit services. The company was founded in 1992 and is based in Kolkata, India.

Similar Companies

Industry: Medical Care Facilities (India)
Name
Market Cap diff.
PE
$11.47B
1.1T INR
7K%
60.9
$10.22B
978.68B INR
7K%
69.0
$7.37B
706.04B INR
5K%
73.6
$3.76B
359.57B INR
2K%
46.2
MEDANTA
$3.14B
300.37B INR
2K%
58.5
$2.78B
266.19B INR
2K%
88.6
Industry: Medical Care Facilities (Global)
Name
Market Cap diff.
PE
$232.18B
852.82B AED
152K%
44.1
$96.73B
63K%
14.9
$26.68B
22.97B EUR
17K%
15.0
$25.58B
22.02B EUR
17K%
24.9
$22.48B
84.42B SAR
15K%
35.2
$21.13B
14K%
24.6
chevron_leftBack